DOI: 10.1055/s-00000140

Pädiatrie up2date

References

Aurora SK, Dodick DW, Diener HC. et al.
Onabotulinumtoxin A for chronic migraine: efficacy, safety and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program.

Acta Neurol Scand 2014;
129: 61-70
doi:10.1111/ane.12171

Download Bibliographical Data

Access: